107 related articles for article (PubMed ID: 7799058)
21. A large pheochromocytoma with invasion of multiple local organs.
Zhu D; Kumar A; Weintraub WS; Rahman E
J Clin Hypertens (Greenwich); 2011 Jan; 13(1):60-4. PubMed ID: 21214723
[No Abstract] [Full Text] [Related]
22. Exploring new frontiers in molecular imaging: Emergence of Ga PET/CT.
Tan EH; Goh SW
World J Radiol; 2010 Feb; 2(2):55-67. PubMed ID: 21160919
[TBL] [Abstract][Full Text] [Related]
23. Use of molecular targeted agents for the diagnosis, staging and therapy of neuroendocrine malignancy.
Hicks RJ
Cancer Imaging; 2010 Oct; 10 Spec no A(1A):S83-91. PubMed ID: 20880795
[TBL] [Abstract][Full Text] [Related]
24. New imaging approaches to phaeochromocytomas and paragangliomas.
Havekes B; King K; Lai EW; Romijn JA; Corssmit EP; Pacak K
Clin Endocrinol (Oxf); 2010 Feb; 72(2):137-45. PubMed ID: 19508681
[TBL] [Abstract][Full Text] [Related]
25. Comparison of 6-18F-fluorodopamine PET with 123I-metaiodobenzylguanidine and 111in-pentetreotide scintigraphy in localization of nonmetastatic and metastatic pheochromocytoma.
Ilias I; Chen CC; Carrasquillo JA; Whatley M; Ling A; Lazúrová I; Adams KT; Perera S; Pacak K
J Nucl Med; 2008 Oct; 49(10):1613-9. PubMed ID: 18794260
[TBL] [Abstract][Full Text] [Related]
26. Usefulness of [111In-DTPA0] octreotide scintigraphy in a family with von Hippel-Lindau disease.
Pulcrano M; Camera L; Pagano L; Del Vecchio S; Ferone D; Bodei L; Murgia A; Pace L; Storto G; Paganelli G; Colao A; Salvatore M; Lombardi G; Biondi B
J Endocrinol Invest; 2008 Apr; 31(4):352-9. PubMed ID: 18475055
[TBL] [Abstract][Full Text] [Related]
27. Somatostatin receptor imaging for neuroendocrine tumors.
de Herder WW; Kwekkeboom DJ; Feelders RA; van Aken MO; Lamberts SW; van der Lely AJ; Krenning EP
Pituitary; 2006; 9(3):243-8. PubMed ID: 17001462
[TBL] [Abstract][Full Text] [Related]
28. Imaging of pheochromocytoma and paraganglioma.
Brink I; Hoegerle S; Klisch J; Bley TA
Fam Cancer; 2005; 4(1):61-8. PubMed ID: 15883712
[TBL] [Abstract][Full Text] [Related]
29. Adrenal medulla.
Greifenkamp JD; DiPette DJ
Curr Hypertens Rep; 1999 Jun; 1(3):241-5. PubMed ID: 10981073
[TBL] [Abstract][Full Text] [Related]
30. The biology and clinical relevance of somatostatin receptor scintigraphy in adrenal tumor management.
Kennedy JW; Dluhy RG
Yale J Biol Med; 1997; 70(5-6):565-75. PubMed ID: 9825485
[TBL] [Abstract][Full Text] [Related]
31. Early massive accumulation of In-111 pentetreotide in a metastatic liver tumor of islet cell carcinoma.
Tsukamoto E; Kanegae K; Itoh K; Okushiba S; Ohno K; Katoh H; Tamaki N
Ann Nucl Med; 1996 Aug; 10(3):339-42. PubMed ID: 8883711
[TBL] [Abstract][Full Text] [Related]
32. The diagnostic utility of somatostatin receptor scintigraphy in oncology.
Valkema R; Steens J; Cleton FJ; Pauwels EK
J Cancer Res Clin Oncol; 1996; 122(9):513-32. PubMed ID: 8781566
[TBL] [Abstract][Full Text] [Related]
33. I-131 MIBG scintigraphy of neuroectodermal tumors. Comparison between I-131 MIBG and In-111 DTPA-octreotide.
Lauriero F; Rubini G; D'Addabbo F; Rubini D; Schettini F; D'Addabbo A
Clin Nucl Med; 1995 Mar; 20(3):243-9. PubMed ID: 7750219
[TBL] [Abstract][Full Text] [Related]
34. [(123)I]metaiodobenzylguanidine and [(111)In]octreotide uptake in begnign and malignant pheochromocytomas.
van der Harst E; de Herder WW; Bruining HA; Bonjer HJ; de Krijger RR; Lamberts SW; van de Meiracker AH; Boomsma F; Stijnen T; Krenning EP; Bosman FT; Kwekkeboom DJ
J Clin Endocrinol Metab; 2001 Feb; 86(2):685-93. PubMed ID: 11158032
[TBL] [Abstract][Full Text] [Related]
35. Pheochromocytoma: diagnosis by scintigraphy using iodine 131 metaiodobenzylguanidine.
Campeau RJ; Garcia OM; Correa OA; Rege AB
South Med J; 1991 Oct; 84(10):1221-30. PubMed ID: 1925724
[TBL] [Abstract][Full Text] [Related]
36. Meta-iodobenzylguanidine in children.
Gelfand MJ
Semin Nucl Med; 1993 Jul; 23(3):231-42. PubMed ID: 8378796
[TBL] [Abstract][Full Text] [Related]
37. Comparison of radiolabeled octreotide and meta-iodobenzylguanidine (MIBG) scintigraphy in malignant pheochromocytoma.
Tenenbaum F; Lumbroso J; Schlumberger M; Mure A; Plouin PF; Caillou B; Parmentier C
J Nucl Med; 1995 Jan; 36(1):1-6. PubMed ID: 7799058
[TBL] [Abstract][Full Text] [Related]
38. Comparison of somatostatin analog and meta-iodobenzylguanidine radionuclides in the diagnosis and localization of advanced neuroendocrine tumors.
Kaltsas G; Korbonits M; Heintz E; Mukherjee JJ; Jenkins PJ; Chew SL; Reznek R; Monson JP; Besser GM; Foley R; Britton KE; Grossman AB
J Clin Endocrinol Metab; 2001 Feb; 86(2):895-902. PubMed ID: 11158063
[TBL] [Abstract][Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
